181 related articles for article (PubMed ID: 22864521)
1. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
2. N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.
Correia I; Costa Pessoa J; Duarte MT; Henriques RT; Piedade MF; Veiros LF; Jakusch T; Kiss T; Dörnyei A; Castro MM; Geraldes CF; Avecilla F
Chemistry; 2004 May; 10(9):2301-17. PubMed ID: 15112220
[TBL] [Abstract][Full Text] [Related]
3. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
4. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
5. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
[TBL] [Abstract][Full Text] [Related]
6. Interaction of vanadyl (VO2+) with ligands containing serine, tyrosine, and threonine.
Ebel M; Rehder D
Inorg Chem; 2006 Sep; 45(18):7083-90. PubMed ID: 16933907
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and structures of oxovanadium(V) complexes of Schiff bases of beta-amino alcohols as tunable catalysts for the asymmetric oxidation of organic sulfides and asymmetric alkynylation of aldehydes.
Hsieh SH; Kuo YP; Gau HM
Dalton Trans; 2007 Jan; (1):97-106. PubMed ID: 17160179
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO
Hon J; Hwang MS; Charnetzki MA; Rashed IJ; Brady PB; Quillin S; Makinen MW
J Biol Inorg Chem; 2017 Dec; 22(8):1267-1279. PubMed ID: 29071441
[TBL] [Abstract][Full Text] [Related]
10. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
11. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
[TBL] [Abstract][Full Text] [Related]
12. Development of an automated protein-tyrosine phosphatase 1B inhibition assay and the screening of putative insulin-enhancing vanadium(IV) and zinc(II) complexes.
Seale AP; de Jesus LA; Kim SY; Choi YH; Lim HB; Hwang CS; Kim YS
Biotechnol Lett; 2005 Feb; 27(4):221-5. PubMed ID: 15742140
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
[TBL] [Abstract][Full Text] [Related]
16. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
[TBL] [Abstract][Full Text] [Related]
18. Biphenyl derived Schiff-base vanadium(V) complexes with pendant OH-groups--structure, characterization and hydrogen peroxide mediated sulfide oxygenation.
Plitt P; Pritzkow H; Kramer R
Dalton Trans; 2004 Aug; (15):2314-20. PubMed ID: 15278124
[TBL] [Abstract][Full Text] [Related]
19. SHP protein tyrosine phosphatase expression in rat uterine tissue.
Phillippe M; Bradley DF; Engle D; Sweet L
J Soc Gynecol Investig; 2006 Jul; 13(5):338-42. PubMed ID: 16814162
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
